top of page
Search

Organovo and BICO Reach Agreement on Bioprinting Patents


April 11, 2022

--

As reported by the Financial Post, Organovo Holdings, Inc. and BICO (formerly Cellink) have reached a broad licensing agreement that will allow BICO and its affiliate companies access to Organovo’s foundational patent portfolio in 3D bioprinting.


Organovo and BICO were previously involved in several legal disputes surrounding the bioprinting patents.


As part of the new patent licence agreement, all civil actions regarding patent infringement and intellectual property rights dealing with the validity of the Organovo patents will reportedly be dismissed and/or terminated.

Authors: Farrah Kudus and Larissa Fulop

 
 
 

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
  • X
  • LinkedIn Icon (Goodmans IP)
  • Goodmans Intellectual Property Web

Keep in touch:

  • X
  • LinkedIn Icon (Goodmans IP)
  • Goodmans Intellectual Property Web
Goodmans LLP, Law, Lawyers

333 Bay Street, Suite 3400, Toronto, ON

© 2019 Goodmans LLP. All right reserved.

bottom of page